Synergistic Cancer Therapies Enhanced by Nanoparticles: Advancing Nanomedicine Through Multimodal Strategies
Cancer remains a formidable global health challenge due to its complex pathophysiology and resistance to conventional treatments. In recent years, the convergence of nanotechnology and oncology has paved the way for innovative therapeutic platforms that address the limitations of traditional modalit...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/17/6/682 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849425670623461376 |
|---|---|
| author | Seyed Mohamad Sadegh Mousavi-Kiasary Ahmood Senabreh Ashkan Zandi Rogelio Pena Frances Cruz Ali Adibi Nasrin Hooshmand |
| author_facet | Seyed Mohamad Sadegh Mousavi-Kiasary Ahmood Senabreh Ashkan Zandi Rogelio Pena Frances Cruz Ali Adibi Nasrin Hooshmand |
| author_sort | Seyed Mohamad Sadegh Mousavi-Kiasary |
| collection | DOAJ |
| description | Cancer remains a formidable global health challenge due to its complex pathophysiology and resistance to conventional treatments. In recent years, the convergence of nanotechnology and oncology has paved the way for innovative therapeutic platforms that address the limitations of traditional modalities. This review examines how nanoparticle (NP)-based strategies enhance the efficacy of chemotherapy, radiotherapy, phototherapy, immunotherapy, and gene therapy by enabling targeted delivery, controlled drug release, and tumor-specific accumulation via the enhanced permeability and retention (EPR) effect. We discuss the design and functionalization of various organic, inorganic, and hybrid NPs, highlighting their roles in improving pharmacokinetics, overcoming multidrug resistance, and modulating the tumor microenvironment. Particular emphasis is placed on dual and multimodal therapies, such as chemo-phototherapy, chemo-immunotherapy, and gene-radiotherapy, that leverage nanoparticle carriers to amplify synergistic effects, minimize systemic toxicity, and improve clinical outcomes. We also explore cutting-edge advances in gene editing and personalized nanomedicine, as well as emerging strategies to address biological barriers and immunosuppressive mechanisms in the tumor niche. Despite the undeniable promise of nanoparticle-based cancer therapies, challenges related to toxicity, scalable manufacturing, regulatory oversight, and long-term biocompatibility must be overcome before they can fully enter clinical practice. By synthesizing recent findings and identifying key opportunities for innovation, this review provides insight into how nanoscale platforms are propelling the next generation of precision oncology. |
| format | Article |
| id | doaj-art-3593dc6c98e548fb9c1a070c1d9ba147 |
| institution | Kabale University |
| issn | 1999-4923 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Pharmaceutics |
| spelling | doaj-art-3593dc6c98e548fb9c1a070c1d9ba1472025-08-20T03:29:40ZengMDPI AGPharmaceutics1999-49232025-05-0117668210.3390/pharmaceutics17060682Synergistic Cancer Therapies Enhanced by Nanoparticles: Advancing Nanomedicine Through Multimodal StrategiesSeyed Mohamad Sadegh Mousavi-Kiasary0Ahmood Senabreh1Ashkan Zandi2Rogelio Pena3Frances Cruz4Ali Adibi5Nasrin Hooshmand6Department of Physical and Environmental Sciences, Texas A&M University-Corpus Christi, Corpus Christi, TX 78412, USADepartment of Physical and Environmental Sciences, Texas A&M University-Corpus Christi, Corpus Christi, TX 78412, USASchool of Electrical and Computer Engineering, Georgia Institute of Technology, Atlanta, GA 30332, USADepartment of Physical and Environmental Sciences, Texas A&M University-Corpus Christi, Corpus Christi, TX 78412, USADepartment of Physical and Environmental Sciences, Texas A&M University-Corpus Christi, Corpus Christi, TX 78412, USASchool of Electrical and Computer Engineering, Georgia Institute of Technology, Atlanta, GA 30332, USADepartment of Physical and Environmental Sciences, Texas A&M University-Corpus Christi, Corpus Christi, TX 78412, USACancer remains a formidable global health challenge due to its complex pathophysiology and resistance to conventional treatments. In recent years, the convergence of nanotechnology and oncology has paved the way for innovative therapeutic platforms that address the limitations of traditional modalities. This review examines how nanoparticle (NP)-based strategies enhance the efficacy of chemotherapy, radiotherapy, phototherapy, immunotherapy, and gene therapy by enabling targeted delivery, controlled drug release, and tumor-specific accumulation via the enhanced permeability and retention (EPR) effect. We discuss the design and functionalization of various organic, inorganic, and hybrid NPs, highlighting their roles in improving pharmacokinetics, overcoming multidrug resistance, and modulating the tumor microenvironment. Particular emphasis is placed on dual and multimodal therapies, such as chemo-phototherapy, chemo-immunotherapy, and gene-radiotherapy, that leverage nanoparticle carriers to amplify synergistic effects, minimize systemic toxicity, and improve clinical outcomes. We also explore cutting-edge advances in gene editing and personalized nanomedicine, as well as emerging strategies to address biological barriers and immunosuppressive mechanisms in the tumor niche. Despite the undeniable promise of nanoparticle-based cancer therapies, challenges related to toxicity, scalable manufacturing, regulatory oversight, and long-term biocompatibility must be overcome before they can fully enter clinical practice. By synthesizing recent findings and identifying key opportunities for innovation, this review provides insight into how nanoscale platforms are propelling the next generation of precision oncology.https://www.mdpi.com/1999-4923/17/6/682nanoparticlessynergistic cancer therapytargeted drug deliverytumor microenvironmentmultimodal treatmentpersonalized oncology |
| spellingShingle | Seyed Mohamad Sadegh Mousavi-Kiasary Ahmood Senabreh Ashkan Zandi Rogelio Pena Frances Cruz Ali Adibi Nasrin Hooshmand Synergistic Cancer Therapies Enhanced by Nanoparticles: Advancing Nanomedicine Through Multimodal Strategies Pharmaceutics nanoparticles synergistic cancer therapy targeted drug delivery tumor microenvironment multimodal treatment personalized oncology |
| title | Synergistic Cancer Therapies Enhanced by Nanoparticles: Advancing Nanomedicine Through Multimodal Strategies |
| title_full | Synergistic Cancer Therapies Enhanced by Nanoparticles: Advancing Nanomedicine Through Multimodal Strategies |
| title_fullStr | Synergistic Cancer Therapies Enhanced by Nanoparticles: Advancing Nanomedicine Through Multimodal Strategies |
| title_full_unstemmed | Synergistic Cancer Therapies Enhanced by Nanoparticles: Advancing Nanomedicine Through Multimodal Strategies |
| title_short | Synergistic Cancer Therapies Enhanced by Nanoparticles: Advancing Nanomedicine Through Multimodal Strategies |
| title_sort | synergistic cancer therapies enhanced by nanoparticles advancing nanomedicine through multimodal strategies |
| topic | nanoparticles synergistic cancer therapy targeted drug delivery tumor microenvironment multimodal treatment personalized oncology |
| url | https://www.mdpi.com/1999-4923/17/6/682 |
| work_keys_str_mv | AT seyedmohamadsadeghmousavikiasary synergisticcancertherapiesenhancedbynanoparticlesadvancingnanomedicinethroughmultimodalstrategies AT ahmoodsenabreh synergisticcancertherapiesenhancedbynanoparticlesadvancingnanomedicinethroughmultimodalstrategies AT ashkanzandi synergisticcancertherapiesenhancedbynanoparticlesadvancingnanomedicinethroughmultimodalstrategies AT rogeliopena synergisticcancertherapiesenhancedbynanoparticlesadvancingnanomedicinethroughmultimodalstrategies AT francescruz synergisticcancertherapiesenhancedbynanoparticlesadvancingnanomedicinethroughmultimodalstrategies AT aliadibi synergisticcancertherapiesenhancedbynanoparticlesadvancingnanomedicinethroughmultimodalstrategies AT nasrinhooshmand synergisticcancertherapiesenhancedbynanoparticlesadvancingnanomedicinethroughmultimodalstrategies |